J-TEC is a bio-venture enterprise founded on the premise that J-TEC will "develop a basic tissue regeneration medical treatment based on the science of tissue engineering, which will bring a qualitative change in medical treatment practices, and thus develop into a business that will transform 21st century medical treatment itself".
The business groups being developed by J-TEC include its "Regenerative Medicine Business", with the main objective of developing, manufacturing and selling tissue-engineered medical products and related products, and as such, is subject to the Pharmaceutical Affairs Law* and a second business group called the "R&D Support Business", which is not subject to this law.
*The Pharmaceutical Affairs Law states that “the objective of this law is to regulate matters necessary for securing the quality, efficacy and safety of pharmaceuticals, quasi-drugs, cosmetics and medical devices, while taking necessary steps to promote research and development of pharmaceuticals and medical devices in high necessity, and thereby improve public health and hygiene.†(Article 1 of the Pharmaceutical Affairs Law)